Logo image of VSTM

VERASTEM INC (VSTM) Stock Fundamental Analysis

USA - NASDAQ:VSTM - US92337C2035 - Common Stock

7.95 USD
+0.14 (+1.79%)
Last: 10/24/2025, 8:01:30 PM
8.06 USD
+0.11 (+1.38%)
Pre-Market: 10/27/2025, 8:38:02 AM
Fundamental Rating

1

VSTM gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 534 industry peers in the Biotechnology industry. VSTM may be in some trouble as it scores bad on both profitability and health. VSTM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year VSTM has reported negative net income.
VSTM had a negative operating cash flow in the past year.
VSTM had negative earnings in each of the past 5 years.
In the past 5 years VSTM always reported negative operating cash flow.
VSTM Yearly Net Income VS EBIT VS OCF VS FCFVSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -66.56%, VSTM is doing worse than 60.30% of the companies in the same industry.
VSTM has a worse Return On Equity (-362.32%) than 73.78% of its industry peers.
Industry RankSector Rank
ROA -66.56%
ROE -362.32%
ROIC N/A
ROA(3y)-88.21%
ROA(5y)-74.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSTM Yearly ROA, ROE, ROICVSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VSTM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VSTM Yearly Profit, Operating, Gross MarginsVSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

2

2. Health

2.1 Basic Checks

VSTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VSTM has been increased compared to 1 year ago.
The number of shares outstanding for VSTM has been increased compared to 5 years ago.
Compared to 1 year ago, VSTM has a worse debt to assets ratio.
VSTM Yearly Shares OutstandingVSTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
VSTM Yearly Total Debt VS Total AssetsVSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

VSTM has an Altman-Z score of -6.66. This is a bad value and indicates that VSTM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of VSTM (-6.66) is worse than 66.85% of its industry peers.
VSTM has a Debt/Equity ratio of 2.25. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.25, VSTM is doing worse than 80.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.25
Debt/FCF N/A
Altman-Z -6.66
ROIC/WACCN/A
WACC8.56%
VSTM Yearly LT Debt VS Equity VS FCFVSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

2.3 Liquidity

VSTM has a Current Ratio of 3.46. This indicates that VSTM is financially healthy and has no problem in meeting its short term obligations.
VSTM has a Current ratio (3.46) which is in line with its industry peers.
VSTM has a Quick Ratio of 3.44. This indicates that VSTM is financially healthy and has no problem in meeting its short term obligations.
VSTM's Quick ratio of 3.44 is in line compared to the rest of the industry. VSTM outperforms 41.57% of its industry peers.
Industry RankSector Rank
Current Ratio 3.46
Quick Ratio 3.44
VSTM Yearly Current Assets VS Current LiabilitesVSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.89% over the past year.
Measured over the past years, VSTM shows a very negative growth in Revenue. The Revenue has been decreasing by -10.55% on average per year.
EPS 1Y (TTM)6.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25.81%
Revenue 1Y (TTM)N/A
Revenue growth 3Y69.6%
Revenue growth 5Y-10.55%
Sales Q2Q%-78.63%

3.2 Future

Based on estimates for the next years, VSTM will show a very strong growth in Earnings Per Share. The EPS will grow by 22.93% on average per year.
The Revenue is expected to grow by 124.75% on average over the next years. This is a very strong growth
EPS Next Y21.9%
EPS Next 2Y17.49%
EPS Next 3Y8.44%
EPS Next 5Y22.93%
Revenue Next Year96.43%
Revenue Next 2Y217.6%
Revenue Next 3Y185.82%
Revenue Next 5Y124.76%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VSTM Yearly Revenue VS EstimatesVSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
VSTM Yearly EPS VS EstimatesVSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -5 -10 -15 -20 -25

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VSTM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VSTM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSTM Price Earnings VS Forward Price EarningsVSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSTM Per share dataVSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.49%
EPS Next 3Y8.44%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VSTM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VERASTEM INC

NASDAQ:VSTM (10/24/2025, 8:01:30 PM)

Premarket: 8.06 +0.11 (+1.38%)

7.95

+0.14 (+1.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-04 2025-11-04
Inst Owners84.58%
Inst Owner Change-0.08%
Ins Owners0.55%
Ins Owner Change-1.56%
Market Cap489.32M
Revenue(TTM)10.00M
Net Income(TTM)-130637000
Analysts85.33
Price Target15.81 (98.87%)
Short Float %31.05%
Short Ratio7.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.76%
Min EPS beat(2)-8.89%
Max EPS beat(2)48.42%
EPS beat(4)2
Avg EPS beat(4)-0.42%
Min EPS beat(4)-61.48%
Max EPS beat(4)48.42%
EPS beat(8)4
Avg EPS beat(8)-0.76%
EPS beat(12)7
Avg EPS beat(12)1.59%
EPS beat(16)8
Avg EPS beat(16)-2.55%
Revenue beat(2)1
Avg Revenue beat(2)-6.6%
Min Revenue beat(2)-100%
Max Revenue beat(2)86.8%
Revenue beat(4)1
Avg Revenue beat(4)-53.3%
Min Revenue beat(4)-100%
Max Revenue beat(4)86.8%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.64%
EPS NQ rev (1m)-1.08%
EPS NQ rev (3m)7.3%
EPS NY rev (1m)-1.57%
EPS NY rev (3m)11.18%
Revenue NQ rev (1m)-5.24%
Revenue NQ rev (3m)14.04%
Revenue NY rev (1m)-4.87%
Revenue NY rev (3m)-1.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 48.93
P/FCF N/A
P/OCF N/A
P/B 13.57
P/tB 23.96
EV/EBITDA N/A
EPS(TTM)-3.11
EYN/A
EPS(NY)-2.17
Fwd EYN/A
FCF(TTM)-1.95
FCFYN/A
OCF(TTM)-1.95
OCFYN/A
SpS0.16
BVpS0.59
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -66.56%
ROE -362.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-88.21%
ROA(5y)-74.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 2.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.46
Quick Ratio 3.44
Altman-Z -6.66
F-Score5
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)35.9%
Cap/Depr(5y)41.04%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25.81%
EPS Next Y21.9%
EPS Next 2Y17.49%
EPS Next 3Y8.44%
EPS Next 5Y22.93%
Revenue 1Y (TTM)N/A
Revenue growth 3Y69.6%
Revenue growth 5Y-10.55%
Sales Q2Q%-78.63%
Revenue Next Year96.43%
Revenue Next 2Y217.6%
Revenue Next 3Y185.82%
Revenue Next 5Y124.76%
EBIT growth 1Y-24.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5Y36.99%
FCF growth 1Y-67.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-67.27%
OCF growth 3YN/A
OCF growth 5YN/A

VERASTEM INC / VSTM FAQ

Can you provide the ChartMill fundamental rating for VERASTEM INC?

ChartMill assigns a fundamental rating of 1 / 10 to VSTM.


What is the valuation status of VERASTEM INC (VSTM) stock?

ChartMill assigns a valuation rating of 0 / 10 to VERASTEM INC (VSTM). This can be considered as Overvalued.


What is the profitability of VSTM stock?

VERASTEM INC (VSTM) has a profitability rating of 0 / 10.